Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

~21 mi. (Medford, Wisconsin, +523 more cities)

Aspirus Medford Hospital

Clear Cell Renal Cell Carcinoma

cabozantinib, +2 more drugs

immunotherapy, +1 more type

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

~21 mi. (Medford, Wisconsin, +576 more cities)

Aspirus Medford Hospital

ERBB2 Amplification, +1 more biomarker

Breast Carcinoma

ado-trastuzumab emtansine, +1 more drug

targeted therapy

Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

~21 mi. (Medford, Wisconsin, +664 more cities)

Aspirus Medford Hospital

PD-L1 High Expression (TPS >= 1%), +1 more biomarker

Non-Small Cell Lung Carcinoma

carboplatin, +2 more drugs

chemotherapy, +1 more type

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

~21 mi. (Medford, Wisconsin, +825 more cities)

Aspirus Medford Hospital

AKT1 Mutation, +91 more biomarkers

Breast Carcinoma, +3 more conditions

adavosertib, +26 more drugs

immunotherapy, +1 more type

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

~21 mi. (Medford, Wisconsin, +656 more cities)

Aspirus Medford Hospital

Deficient DNA Mismatch Repair (dMMR), +8 more biomarkers

Colon Adenocarcinoma, +1 more condition

atezolizumab, +3 more drugs

chemotherapy, +1 more type

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

~21 mi. (Medford, Wisconsin, +533 more cities)

Aspirus Medford Hospital

ERBB2 Amplification, +1 more biomarker

Invasive Breast Carcinoma

ado-trastuzumab emtansine, +6 more drugs

chemotherapy, +2 more types

S0820, Adenoma and Second Primary Prevention Trial

~21 mi. (Medford, Wisconsin, +616 more cities)

Aspirus Medford Hospital

Colon Carcinoma, +1 more condition

eflornithine, +2 more drugs

chemotherapy, +1 more type

Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

~21 mi. (Medford, Wisconsin, +497 more cities)

Aspirus Medford Hospital

HER2 Positive

Breast Adenocarcinoma

atezolizumab, +4 more drugs

chemotherapy, +2 more types

Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

~21 mi. (Medford, Wisconsin, +469 more cities)

Aspirus Medford Hospital

Non-Small Cell Lung Carcinoma

carboplatin, +6 more drugs

chemotherapy, +2 more types

A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma

~21 mi. (Medford, Wisconsin, +413 more cities)

Aspirus Medford Hospital

BRAF Mutation

Melanoma

ipilimumab, +2 more drugs

immunotherapy, +1 more type

Testing The Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia

~21 mi. (Medford, Wisconsin, +556 more cities)

Aspirus Medford Hospital

CD19 Expression, +2 more biomarkers

Chronic Lymphocytic Leukemia

ibrutinib, +2 more drugs

chemotherapy, +2 more types

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

~21 mi. (Medford, Wisconsin, +225 more cities)

Aspirus Medford Hospital

Bladder Urothelial Carcinoma

atezolizumab, +5 more drugs

chemotherapy, +2 more types